PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 159 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2018. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $159 | -100.0% | 19 | -99.9% | 0.00% | -100.0% |
| Q2 2023 | $446,042 | +3716916.7% | 33,537 | +3353600.0% | 0.00% | – |
| Q1 2023 | $12 | +50.0% | 1 | 0.0% | 0.00% | – |
| Q4 2022 | $8 | -99.2% | 1 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -95.0% | 1 | -100.0% | 0.00% | – |
| Q2 2022 | $20,000 | -99.0% | 4,609 | -92.2% | 0.00% | -100.0% |
| Q1 2021 | $1,966,000 | -84.2% | 59,024 | -87.7% | 0.00% | -84.0% |
| Q4 2020 | $12,442,000 | +279.9% | 479,636 | +44.5% | 0.02% | +212.5% |
| Q3 2020 | $3,275,000 | -62.2% | 331,846 | -79.3% | 0.01% | -60.0% |
| Q3 2018 | $8,656,000 | +216300.0% | 1,600,000 | +277677.8% | 0.02% | – |
| Q2 2016 | $4,000 | -20.0% | 576 | -5.4% | 0.00% | – |
| Q1 2016 | $5,000 | 0.0% | 609 | -27.3% | 0.00% | – |
| Q1 2015 | $5,000 | – | 838 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 1,446,459 | $48,182,000 | 7.22% |
| BOURNE LENT ASSET MANAGEMENT INC | 536,800 | $17,881,000 | 5.70% |
| Casdin Capital, LLC | 5,000,000 | $166,550,000 | 4.96% |
| Iron Triangle Partners LP | 935,805 | $31,172,000 | 3.96% |
| Jackson Square Partners, LLC | 12,911,695 | $430,088,000 | 2.44% |
| SB Management Ltd | 9,861,089 | $328,473,000 | 2.12% |
| Abacus Planning Group, Inc. | 180,000 | $5,996,000 | 1.92% |
| BERKSHIRE CAPITAL HOLDINGS INC | 413,800 | $13,784,000 | 1.57% |
| ARK Investment Management | 21,301,191 | $709,543,000 | 1.41% |
| Nikko Asset Management Americas, Inc. | 5,247,237 | $174,785,000 | 0.86% |